Parsaclisib in Newly Diagnosed Stage I-IIIC Triple Negative or HER2+ Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Sitravatinib in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)
- Status
- COMPLETED
- Phase
- NA
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
- Status
- UNKNOWN
- Phase
- PHASE1
Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBC
- Status
- WITHDRAWN
- Phase
- NA
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC
- Status
- COMPLETED
- Phase
- PHASE1